Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

S. Craig Tidwell, Hong Nerng Ho, Wen Hsin Chiu, Ronald J. Torry, Donald S. Torry

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

OBJECTIVE: Maternal serum placenta growth factor levels have been shown to be significantly reduced in women with established preeclampsia. However, the temporal change in serum placenta growth factor levels before the clinical onset of preeclampsia is not known. STUDY DESIGN: Serum samples were collected from patients at the first prenatal (5-15 weeks' gestation), second-trimester (16-20 weeks' gestation), and third-trimester (26-30 weeks' gestation) visits. Serum placenta growth factor levels were determined and analyzed according to pregnancy outcome. RESULTS: Maternal placenta growth factor levels during normal gestation increased dramatically from the first to the third trimester. At the same gestational time points, in contrast, significantly lower serum placenta growth factor levels were found in patients in whom mild or severe preeclampsia eventually developed (P < .01). Low maternal serum placenta growth factor levels during early gestation were associated with a significant odds ratio for development of preeclampsia (P < .005). CONCLUSION: Relatively decreased levels of serum placenta growth factor occur before the onset of clinical preeclampsia, which suggests that placenta growth factor measurement could be used to discriminate those pregnancies predisposed to development of preeclampsia.

Original languageEnglish
Pages (from-to)1267-1272
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume184
Issue number6
DOIs
Publication statusPublished - Jan 1 2001
Externally publishedYes

Fingerprint

Pre-Eclampsia
Mothers
Serum
Pregnancy
Third Pregnancy Trimester
Placenta Growth Factor
Second Pregnancy Trimester
Pregnancy Outcome
Odds Ratio

Keywords

  • Placenta growth factor
  • Preeclampsia
  • Pregnancy
  • Trophoblast

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. / Tidwell, S. Craig; Ho, Hong Nerng; Chiu, Wen Hsin; Torry, Ronald J.; Torry, Donald S.

In: American Journal of Obstetrics and Gynecology, Vol. 184, No. 6, 01.01.2001, p. 1267-1272.

Research output: Contribution to journalArticle

Tidwell, S. Craig ; Ho, Hong Nerng ; Chiu, Wen Hsin ; Torry, Ronald J. ; Torry, Donald S. / Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. In: American Journal of Obstetrics and Gynecology. 2001 ; Vol. 184, No. 6. pp. 1267-1272.
@article{223753f006504fc5acfb3d2344dbc379,
title = "Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia",
abstract = "OBJECTIVE: Maternal serum placenta growth factor levels have been shown to be significantly reduced in women with established preeclampsia. However, the temporal change in serum placenta growth factor levels before the clinical onset of preeclampsia is not known. STUDY DESIGN: Serum samples were collected from patients at the first prenatal (5-15 weeks' gestation), second-trimester (16-20 weeks' gestation), and third-trimester (26-30 weeks' gestation) visits. Serum placenta growth factor levels were determined and analyzed according to pregnancy outcome. RESULTS: Maternal placenta growth factor levels during normal gestation increased dramatically from the first to the third trimester. At the same gestational time points, in contrast, significantly lower serum placenta growth factor levels were found in patients in whom mild or severe preeclampsia eventually developed (P < .01). Low maternal serum placenta growth factor levels during early gestation were associated with a significant odds ratio for development of preeclampsia (P < .005). CONCLUSION: Relatively decreased levels of serum placenta growth factor occur before the onset of clinical preeclampsia, which suggests that placenta growth factor measurement could be used to discriminate those pregnancies predisposed to development of preeclampsia.",
keywords = "Placenta growth factor, Preeclampsia, Pregnancy, Trophoblast",
author = "Tidwell, {S. Craig} and Ho, {Hong Nerng} and Chiu, {Wen Hsin} and Torry, {Ronald J.} and Torry, {Donald S.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1067/mob.2001.113129",
language = "English",
volume = "184",
pages = "1267--1272",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

AU - Tidwell, S. Craig

AU - Ho, Hong Nerng

AU - Chiu, Wen Hsin

AU - Torry, Ronald J.

AU - Torry, Donald S.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - OBJECTIVE: Maternal serum placenta growth factor levels have been shown to be significantly reduced in women with established preeclampsia. However, the temporal change in serum placenta growth factor levels before the clinical onset of preeclampsia is not known. STUDY DESIGN: Serum samples were collected from patients at the first prenatal (5-15 weeks' gestation), second-trimester (16-20 weeks' gestation), and third-trimester (26-30 weeks' gestation) visits. Serum placenta growth factor levels were determined and analyzed according to pregnancy outcome. RESULTS: Maternal placenta growth factor levels during normal gestation increased dramatically from the first to the third trimester. At the same gestational time points, in contrast, significantly lower serum placenta growth factor levels were found in patients in whom mild or severe preeclampsia eventually developed (P < .01). Low maternal serum placenta growth factor levels during early gestation were associated with a significant odds ratio for development of preeclampsia (P < .005). CONCLUSION: Relatively decreased levels of serum placenta growth factor occur before the onset of clinical preeclampsia, which suggests that placenta growth factor measurement could be used to discriminate those pregnancies predisposed to development of preeclampsia.

AB - OBJECTIVE: Maternal serum placenta growth factor levels have been shown to be significantly reduced in women with established preeclampsia. However, the temporal change in serum placenta growth factor levels before the clinical onset of preeclampsia is not known. STUDY DESIGN: Serum samples were collected from patients at the first prenatal (5-15 weeks' gestation), second-trimester (16-20 weeks' gestation), and third-trimester (26-30 weeks' gestation) visits. Serum placenta growth factor levels were determined and analyzed according to pregnancy outcome. RESULTS: Maternal placenta growth factor levels during normal gestation increased dramatically from the first to the third trimester. At the same gestational time points, in contrast, significantly lower serum placenta growth factor levels were found in patients in whom mild or severe preeclampsia eventually developed (P < .01). Low maternal serum placenta growth factor levels during early gestation were associated with a significant odds ratio for development of preeclampsia (P < .005). CONCLUSION: Relatively decreased levels of serum placenta growth factor occur before the onset of clinical preeclampsia, which suggests that placenta growth factor measurement could be used to discriminate those pregnancies predisposed to development of preeclampsia.

KW - Placenta growth factor

KW - Preeclampsia

KW - Pregnancy

KW - Trophoblast

UR - http://www.scopus.com/inward/record.url?scp=0035339698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035339698&partnerID=8YFLogxK

U2 - 10.1067/mob.2001.113129

DO - 10.1067/mob.2001.113129

M3 - Article

VL - 184

SP - 1267

EP - 1272

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -